PF-00489791
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PF-00489791, covering 2016-09-16 to 2021-10-11. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure [Phase 2]